Combined treatment of marizomib and cisplatin modulates cervical cancer growth and invasion and enhances antitumor potential in vitro and in vivo

Proteasome inhibition is an attractive approach for anticancer therapy. Cisplatin (cis-diamminedichloroplatinum, CDDP) is widely used as a standard chemotherapy drug in the treatment of solid malignant tumors, such as cervical cancer, ovarian cancer, colorectal cancer, and lung cancer. However, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ziruizhuo, Zhang, Songcheng, Lin, Bingjie, Wang, Qixin, Nie, Xiaojing, Shi, Yonghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468930/
https://www.ncbi.nlm.nih.gov/pubmed/36110967
http://dx.doi.org/10.3389/fonc.2022.974573

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468930/
https://www.ncbi.nlm.nih.gov/pubmed/36110967
http://dx.doi.org/10.3389/fonc.2022.974573

Ejemplares similares